Changes in the incidence of coelic disease was studied among children born in Goteborg, Sweden, between 1970 and 1988 . A total of 188 patients with coeliac disease were found. Of these, 83% were less than 2 years old at the time of their first duodenal biopsy and 74% of them have so far been verified according to
Since the middle of the 1970s, coeliac disease in childhood has been reported to be decreasing in England," Scotland,s and Ireland. 6 The incidence and clinical picture have remained unchanged in Italy. 7 In Finland a decrease in the number of cases diagnosed, together with a changing clinical pattern of a late start and mild course, led to the conclusion that the real incidence was probably unchanged. 8 In this study we report the changes in the incidence of childhood coeliac disease during the last 20 years in Goteborg, the second largest city in Sweden, which had 435 842 inhabitants in 1979 (the middle of the study period) and a computer based population register. The city, like Sweden in general, has a comprehensive child health service with child health centres attended by 98% of all infants and young children. 2) . The last figure is a minimum, because In the group in which coeliac disease had been diagnosed before the age of 2 years, the age at the onset of symptoms increased from a mean of 6-7 months in the first half of the observation period to 8-2 months in the second half (p<00004, b=0-17, SE 0-05).
The age at diagnosis increased from a mean of 12-4 months in the first half of the observation period to 13-4 in the last five months (p<0O05, b=0-14, SE 0-07). The mean time between onset and diagnosis did not change significantly, being 5 3 months for the whole period.
Weight at the time of diagnosis among children with coeliac disease diagnosed before the age of 2 years was generally far below the reference mean (fig 3) . When a linear regression was fitted to the data, a slight but significant increase was found (p=0-0001, b=0-06, SE 0-02), but variations in weight increased during the second half of the 1980s.
Discussion
We have retrospectively studied the incidence of coeliac disease in birth cohorts born in Goteborg from 1970 to 1988, and found a threefold increase over the period. Of the 188 children studied, 83% were less than 2 years old at the time of the first small intestinal biopsy.
The first Swedish studies of children using the same diagnostic criteria as we used showed an incidence of between 1-02 and 1-16/1000 liveborn infants. 14 15 Later reports showed that the incidence was unchanged.'1-8 In another Swedish study 1866 healthy blood donors were tested with antigliadin antibodies and those with increased titres were offered a small intestinal biopsy.19 An incidence of coeliac disease of 3-7/1000 was found.
In other parts of Europe, coeliac disease was reported to be increasing until the middle of the 1970s.'1 4 5 One important problem of longitudinal epidemiological studies is that of the duration of observation periods of the different birth cohorts (fig 4) . To avoid a systematic error with overestimation of the incidence in the older cohorts, it is necessary to maintain the same observation time. A choice must be made between a shorter observation time that will exclude the cases that were diagnosed later, and a longer observation time resulting in a long delay before changes can be identified.
Another problem arises when the total population is divided by the number of cases. The cases must be derived from the birth cohorts which constitute the population at risk. In this study children from the surrounding areas treated in the department, and children who had moved to Goteborg before or after the diagnosis was made, were excluded. Children with coeliac disease who were born in Goteborg but in whom the diagnosis was made after they had moved away from the city were impossible to trace and therefore could not be included in the study. Consequently our cumulative incidence represents a minimum. The number of liveborn children in Goteborg varied between 4845 and 6694/year during the study period.
The migration of the population is yet another problem in epidemiological studies. The inward migration of cases and population was well controlled in this study. The occurrence of coeliac disease in the population is not likely to differ between the part of the population that stays and the one that migrates out of the city. As we divided the number of cases into the number of liveborn infants, however, and not into the actual number of the cohort who lived in Goteborg, there will be a systematic error that will increase with migration out of the city related to a longer observation time. The number of children with coeliac disease within the birth cohort but in whom the disease was diagnosed after they had moved away from the city will also add to the systematic error with the observation time. There are two ways to adjust for these processes: one is to use a 'life- In the last cohorts a lower proportion of cases have fulfilled the ESPGAN criteria so far. This could not explain the observed increase, however, because the number with transient gluten intolerance is low and has been decreasing in our area, as in other parts of Sweden. 18 In addition, all doubtful cases were excluded from the study.
The increase could consequently not be explained by systematic errors or shortcomings in the methods used. Could it be the result of improved detection? Throughout the study, the same diagnostic criteria were used, and the biopsy specimens were examined by the same two pathologists. The ability to detect and interpret deviations in growth velocity, however, is thought to have improved among physicians and nurses at child health centres. Screening tests for antigliadin antibodies have been in clinical use in the area since the beginning of the 1980s. There is also an increasing awareness of the existence of coeliac disease both among medical staff and the general public. Consequently there has been an increase in the number of small intestinal biopsies done in the department during the study period, and the weight for age at diagnosis has slightly increased (fig 3) . All these factors support improved detection as an explanation for the increased incidence. On the other hand, the cases with high weight SD scores could only explain part of the increase (fig 3) and the delay between the onset of symptoms and diagnosis did not change significantly. We also doubt that a different rate of detection could be the sole reason for the different incidence trends in different countries. This indicates that detection bias could only partly explain the observed increase.
We have found a threefold increase in the incidence of coeliac disease over the last 20 years. Our data indicate that only a small part of this increase may be explained by increased diagnostic activities or improved clinical detection or screening. Other factors that may influence the incidence of coeliac disease, such as feeding patterns and gluten consumption, are currently being investigated.
